Message from the Chairman
Dear Shareholders, Service Recipients, and Partners,
Throughout its 38 years of operation, Ramkhamhaeng Hospital Public Company Limited has remained committed to delivering healthcare services with warmth and professional expertise. The Company continues to uphold high medical standards through a team of specialized physicians in order to meet the diverse healthcare needs of the public.
In 2025, the Company continued to focus on responding to the evolving landscape of the healthcare system, rapid advancements in medical technology, and the growing demand for more personalized medical services. The Group has consistently invested in modern and internationally standardized medical technologies to enhance the accuracy, safety, and effectiveness of treatments.
Notable medical innovations include intraoperative detection of parathyroid tissue, which helps preserve parathyroid glands responsible for hormone production during thyroid surgery. The introduction of Endoscopic Ultrasound (EUS) allows physicians to examine deep structural abnormalities within the gastrointestinal tract while performing endoscopy, enabling precise localization for tissue biopsy procedures.
In surgical treatment, microincision surgery has become a widely accepted standard. Ramkhamhaeng Hospital provides minimally invasive surgical services across multiple specialties, including surgery, obstetrics and gynecology, orthopedics, ear–nose–throat (ENT), and cardiovascular surgery. This approach enhances surgical precision while reducing pain, minimizing incision size, and allowing faster patient recovery compared with conventional surgery.
The Ramkhamhaeng Hospital Heart Center provides comprehensive services for cardiovascular diseases, including diagnosis, treatment, surgery, and catheter-based interventions. In 2025, the Center introduced Pulsed Field Ablation (PFA) technology for the treatment of cardiac arrhythmias, which offers higher precision and safety in eliminating abnormal electrical signals in the heart.
In response to the growing prevalence of osteoporosis and sarcopenia, particularly among the elderly and individuals with limited physical activity, the Company has introduced advanced diagnostic technologies, including DEXA Scan and Bioelectrical Impedance Analysis (BIA), to support screening and diagnosis of bone density loss and muscle mass reduction.
In cancer care, the Radiation Therapy Center at Ramkhamhaeng 2 Hospital utilizes advanced 4D radiation therapy technology, which synchronizes radiation delivery with the patient’s breathing motion. This technology improves treatment accuracy, reduces the impact on surrounding healthy tissues, and enhances safety and treatment outcomes.
The Group has also expanded cancer treatment capabilities in regional areas through the Radiation Therapy Center at Chiang Rai Ram Hospital. Meanwhile, the Vibharam Hospital Group has strengthened its medical laboratory services and Nuclear Medicine capabilities to enhance diagnostic potential across affiliated hospitals.
In addition, Vibharam Hospital Group places emphasis on providing healthcare services for insured persons under the Social Security Scheme, allowing patients to combine social security benefits with private health insurance coverage. This approach helps reduce treatment costs while expanding healthcare access for patients
The Company also recognizes the importance of strengthening the foundation of medical education and continuously developing human resources to support future changes in medical technologies and treatment models. Key initiatives include promoting knowledge in genomic medicine, such as genetic sequencing using Next-Generation Sequencing (NGS) technology, which supports the development of personalized cancer treatment and targeted therapy. Training programs have also been conducted in collaboration with international experts from Mayo Clinic, USA, particularly in the field of cardiopulmonary rehabilitation and the use of Cardiopulmonary Exercise Testing (CPET). In addition, the Company promotes knowledge management and multidisciplinary treatment approaches to enhance comprehensive patient care.
In driving the organization through digital innovation, the Company continues its Digital Transformation toward becoming a Smart Hospital. This includes the development of integrated patient information management systems and the RAM Health Mart application, which facilitates patient access to treatment information and healthcare services. The Company has also developed new systems that enable effective data connectivity among affiliated hospitals and is preparing to integrate Artificial Intelligence (AI) technologies to support patient data management, improving accuracy, safety, and operational efficiency.
Beyond continuously improving medical services, the Company also places great importance on enhancing patient experience and comfort. Various facility improvements have been undertaken, including the expansion of service areas in new buildings, renovation of patient rooms to provide modern and comfortable environments, and upgrades to examination rooms and supporting facilities such as waiting areas, restaurants, convenience stores, and valet parking services for the convenience of all visitors.
The Board of Directors remains committed to overseeing the Company’s operations in alignment with its strategic goals, strengthening the organization’s capabilities and readiness to meet the healthcare needs of people across all regions, while supporting the Company’s stable and sustainable growth.
On behalf of the Board of Directors, I would like to express my sincere appreciation to all shareholders, service recipients, and partners for your continued trust and support. I would also like to thank our doctors, nurses, and all personnel whose dedication is the key driving force behind Ramkhamhaeng Hospital’s continued growth. The Company will continue to uphold good corporate governance while advancing medical technology and standards to create sustainable value for Thai society.